Page 102 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1
P. 102
34. Lee JY, Simon RA, Stevenson DD. Se- 42. Berges-Gimeno MP, Simon RA, Ste-
lection of aspirin dosages for aspirin de- venson DD. The effect of leukot-
severe asthma forum 1: severe asthma - basic and clinical views sensitization treatment in patients with riene-modifier drugs on aspirin-induced
aspirin-exacerbated respiratory dis- asthma and rhinitis reactions. Clin Exp
ease. J Allergy Clin Immunol. 2007 Allergy. 2002 Oct;32(10):1491-6.
Jan;119(1):157-64.
43. Giavina-Bianchi P, Caiado J, Picard M,
35. Chen JR, Buchmiller BL, Khan DA. et al. Rapid desensitization to chemo-
An Hourly Dose-Escalation Desen- therapy and monoclonal antibod-
sitization Protocol for Aspirin-Exac- ies is effective and safe. Allergy. 2013
erbated Respiratory Disease. J aller- Nov;68(11):1483-4.
gy Clin Immunol Pract. 2015 Nov-
Dec;3(6):926-31.e1. 44. Thong YH T, Mirakian R, Castells M,
et al. A world allergy organization in-
36. Makowska J, Lewandowska-Polak A, ternational survey on diagnostic proce-
Kowalski ML. Hypersensitivity to As- dures and therapies in drug allergy/hy-
pirin and other NSAIDs: Diagnos- persensitivity. World Allergy Organ J.
tic Approach in Patients with Chron- 2011 Dec;4(12):257-70.
ic Rhinosinusitis. Curr Allergy Asthma
Rep. 2015 Aug;15(8):47. doi: 10.1007/ 45. Burnett T, Katial R, Alam R. Mech-
s11882-015-0552-y. anisms of aspirin desensitization. Im-
munol Allergy Clin North Am. 2013
37. Hope AP, Woessner KA, Simon RA, et May;33(2):223-36.
al. Rational approach to aspirin dos-
ing during oral challenges and desensi- 46. Eraso I, Sangiovanni S, Morales
tization of patients with aspirin-exacer- EI, et al. Aspirin desensitization in
bated respiratory disease. J Allergy Clin NSAID-exacerbated respiratory disease
Immunol. 2009 Feb;123(2):406-10. and its outcomes in the clinical course
of asthma: A systematic review of the
38. Agondi RC, Dias GMFS, Assis JP de, et literature and meta-analysis. PLoS
al. Hypersensitivity to dipyrone in as- One. 2021 Mar 26;16(3):e0247871. doi:
pirin-exacerbated respiratory disease 10.1371/journal.pone.0247871.
patients is associated with urticaria.
Respir Med. 2020 Aug-Sep;170:106041. 47. Cheong Z, Tan CYL, Lim CP, et al. Pa-
doi: 10.1016/j.rmed.2020.106041. tient characterization and predictors of
aspirin desensitization response. Asia
39. Rodríguez-Jiménez JC, Moreno-Paz FJ, Pac Allergy. 2021 Apr 27;11(2):e10. doi:
Terán LM, et al. Aspirin exacerbated 10.5415/apallergy.2021.11.e20.
respiratory disease: Current topics and
trends. Respir Med. 2018 Feb 1;135:62- 48. Waldram JD, Simon RA. Performing
75. Aspirin Desensitization in Aspirin-Ex-
acerbated Respiratory Disease. Im-
40. Glicksman JT, Parasher AK, Doghram- munol Allergy Clin North Am. 2016
ji L, et al. Alcohol-induced respiratory Nov;36(4):693-703.
symptoms improve after aspirin desen-
sitization in patients with aspirin-exac- 49. Tyrak KE, Pajdzik K, Jakieła B, et al.
erbated respiratory disease. Int Forum Biomarkers for predicting response to
Allergy Rhinol. 2018 Oct;8(10):1093-7. aspirin therapy in aspirin‐exacerbated
respiratory disease. Clin Exp Allergy.
41. Ta V, White AA. Survey-Defined Pa- 2021 Aug;51(8):1046-56.
tient Experiences With Aspirin-Ex-
acerbated Respiratory Disease. J Al- 50. Kowalski ML, Wardzyńska A, Ma-
lergy Clin Immunol Pract. 2015 Sep- kowska JS. Clinical Trials of Aspirin
Oct;3(5):711-8. Treatment After Desensitization in As-
pirin-Exacerbated Respiratory Disease.
   97   98   99   100   101   102   103   104   105   106   107